title: How Far Could We Go with Open Data - A Case Study for TRPV1 Antagonists.
abstract: Publicly open databases of small compounds have become an indispensable tool for chemoinformaticians for collection and preparation of datasets suitable for drug discovery questions. Since these databases comprise compounds coming from structure-activity relationship (SAR) studies performed by different research groups, they are very diverse with respect to the biological assays used. In the present study we analyzed the applicability of a thoroughly curated dataset gathered from open sources for ligand-based studies, using the transient receptor potential vanilloid type 1 (TRPV1) as use case. Thorough curation of compounds according to the biological assay type and conditions led to a dataset of comparable bioactive chemicals. Subsequent exhaustive analysis of the obtained dataset using classification algorithms demonstrated that the models obtained in most of the cases possess reliable quality. Analysis of constantly misclassified compounds showed that they belong to local SAR series, where small changes in structure lead to different class labels. These small structural differences could not be captured by the classification algorithms. However application of the 3D alignment-independent QSAR technique GRIND for local, structurally related series overcomes this problem.
authors: Department of Medicinal Chemistry, University of Vienna Althanstr. 14, 1090 Vienna, Austria phone: +43-1-4277-55110.
authors: Daria A
authors: DA
authors: Tsareva
authors: Gerhard F
authors: GF
authors: Ecker
keywords: Classification; GRIND; Open data; TRPV1
references: J Mol Graph Model. 2000 Aug-Oct;18(4-5):464-77
references: 11143563
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D534-8
references: 21087994
references: J Comput Aided Mol Des. 2009 Apr;23(4):195-8
references: 19194660
references: Mol Inform. 2012 Aug;31(8):599-609
references: 23293680
references: J Med Chem. 2010 Apr 22;53(8):3330-48
references: 20307063
references: J Chem Inf Model. 2008 Sep;48(9):1813-23
references: 18693718
references: AAPS J. 2010 Sep;12(3):361-70
references: 20440589
references: J Chem Inf Comput Sci. 2003 Nov-Dec;43(6):1947-58
references: 14632445
references: Bioorg Med Chem Lett. 2010 Jun 1;20(11):3291-4
references: 20457518
references: Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S29-39
references: 11033425
references: Biochem Pharmacol. 2009 Aug 1;78(3):211-6
references: 19481638
references: Bioorg Med Chem Lett. 2009 Jan 1;19(1):40-6
references: 19038548
references: Drug Discov Today. 2012 Nov;17(21-22):1188-98
references: 22683805
references: Bioinformatics. 2000 May;16(5):412-24
references: 10871264
references: Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41
references: 21059682
references: Mol Inform. 2012 Aug;31(8):528-535
references: 23226167
references: Bioorg Med Chem Lett. 2008 Feb 1;18(3):1072-8
references: 18155908
references: J Med Chem. 2000 Aug 24;43(17):3233-43
references: 10966742
references: Bioorg Med Chem Lett. 2004 Jun 21;14(12):3053-6
references: 15149643
references: J Chem Inf Comput Sci. 2001 Mar-Apr;41(2):446-50
references: 11277735